Loading...
The Case for Low Blood Pressure Targets
The “totality” of hypertension clinical trial endpoint data has shown that the absolute benefit of pharmacological blood pressure (BP) lowering is directly related to the BP level and baseline cardiovascular risk, albeit with attenuation of the relative risk reduction per unit of BP lowering in pati...
Saved in:
| Published in: | Am J Hypertens |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Oxford University Press
2017
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5155566/ https://ncbi.nlm.nih.gov/pubmed/27572960 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ajh/hpw087 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|